Ambiq Micro, Inc.
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Ambiq Micro, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 22.80 $ to 90.50 $ · Last price: 65.50 $ (As of: September 18, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Semiconductors
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Ambiq Micro, Inc. AMBQ | 1.6 | – | 0.0 | 43.6 | -46.6 | -4.7 | 89.1 |
| NVIDIA Corporation NVDA | 5,616.1 | 30.8 | 22.4 | 74.7 | 65.6 | 65.5 | 26.4 |
| Broadcom Inc AVGO | 1,701.3 | 56.8 | 33.7 | 75.5 | 49.0 | 23.9 | 4.3 |
| Micron Technology Inc MU | 1,319.6 | 21.5 | 15.8 | 72.6 | 80.4 | 48.9 | 502.4 |
| Advanced Micro Devices Inc AMD | 968.6 | 182.5 | 77.8 | 55.7 | 14.4 | 34.3 | 254.5 |
| Intel Corporation INTC | 545.8 | – | 145.4 | 38.9 | 6.9 | -0.5 | 255.3 |
| Arm Holdings plc ARM | 294.4 | 278.4 | 222.4 | 97.5 | 7.6 | 22.8 | 88.1 |
| Texas Instruments Incorporated TXN | 242.6 | 41.0 | 26.1 | 58.3 | 37.8 | 13.1 | 50.6 |
| Marvell Technology Group Ltd MRVL | 235.8 | 80.8 | 45.0 | 52.2 | 14.5 | 42.1 | 229.8 |
| Median of companies shown | 545.8 | 56.8 | 33.7 | 58.3 | 14.5 | 23.9 | 89.1 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2020 | 51 | -20 | -25 | -1.85 | -35 | 92 | 100 |
| 2021 | 91 | -25 | -25 | -0.10 | -53 | 89 | 105 |
| 2023 | 66 | -51 | -50 | -4.81 | -27 | 59 | 72 |
| 2024 | 76 | -41 | -40 | -2.91 | -21 | 86 | 104 |
| 2025 | 73 | -41 | -36 | -4.57 | -20 | 162 | 185 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -25.99 | – | 20 | – | -50.10 | 0 | 0 |
| 2025: Q1 | -0.61 | – | 16 | 3.40 | -52.70 | 1 | 0 |
| 2025: Q2 | -0.48 | – | 18 | -11.70 | -47.50 | -12 | -14 |
| 2025: Q3 | -0.72 | – | 18 | -10.40 | -49.60 | -5 | -6 |
| 2025: Q4 | -0.58 | – | 21 | 2.00 | -51.50 | -4 | -4 |
| 2026: Q1 | -0.50 | – | 25 | 59.30 | -40.60 | -11 | -12 |
| 2026: Q2 | -0.32 | 33.30 | 34 | 89.40 | -20.90 | -10 | -10 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 20 of our scanner strategies — each hit links to the scanner.
Growth
Quality & Balance Sheet
Breakout & Setup
Momentum & Trend
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- CANSLIM Type RS
- High ADR (≥5%)
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Power Trend Leader
- Oliver Kell: Doublers
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 2
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.53 | -0.58 – -0.50 | 135 | 79.6% | 6 |
| 12/31/2027 | -0.23 | -0.45 – -0.04 | 177 | 56.7% | 6 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -5.5%
- More than 10% revenue growth is expected for the coming year 25.5%
- Share count grows by less than 3% a year -57.7%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -42.1%
- Gross margin at 40% or higher and without meaningful erosion 35.4%
- Goodwill from acquisitions does not grow faster than revenue 0.0%
- Net debt below twice EBITDA 140 m net cash
- Operating cash flow covers the profits of the last three years 58 m
- Return on capital at 15% or higher, or up versus two years ago -24.9%
- Insiders hold at least 10% or are net buyers 5.7%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
5/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 7.3%
- Exp. sales growth 3Y > 5% 56.4%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% 56.4%
- Net debt < 4x EBIT –
- EBIT positive, 10Y straight –
- Max. EBIT decline < 50% –
- Return on equity > 15% -24.2%
- ROCE > 15% -24.9%
- Expected return > 10% 53.7%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Hanson Scott McLean | Chief Technology Officer | Sell | 100 | 61.00 | 6,100 |
| Sep 15, 2026 | Hanson Scott McLean | Chief Technology Officer | Sell | 4,947 | 60.56 | 299,573 |
| Sep 15, 2026 | Hanson Scott McLean | Chief Technology Officer | Sell | 1,953 | 59.53 | 116,270 |
| Sep 15, 2026 | Hanson Scott McLean | Chief Technology Officer | Other | 7,000 | 8.12 | 56,840 |
| Sep 15, 2026 | Esaka Fumihide | Chief Executive Officer | Sell | 100 | 61.00 | 6,100 |
| Sep 15, 2026 | Esaka Fumihide | Chief Executive Officer | Sell | 9,615 | 60.55 | 582,171 |
| Sep 15, 2026 | Esaka Fumihide | Chief Executive Officer | Sell | 3,785 | 59.56 | 225,444 |
| Sep 15, 2026 | Esaka Fumihide | Chief Executive Officer | Other | 13,500 | 8.12 | 109,620 |
| Sep 14, 2026 | Chen Sean Chihhsiang | President and COO | Sell | 1,400 | 60.83 | 85,166 |
| Sep 14, 2026 | Chen Sean Chihhsiang | President and COO | Sell | 11,000 | 60.24 | 662,618 |
The company
About the Company
Ambiq Micro, Inc. bietet ultra-stromsparende Halbleiterlösungen in den USA, Europa, Asien und international an.
- Employees
- 200
- Headquarters
- Austin, TX
- Address
- 6500 River Place Boulevard, 78730 Austin, United States
- Phone
- 512 879 2850
- Website
- ambiq.com
- IPO Date
- 07/30/2025
- ISIN
- US0231931058
Management
| Name | Title | Birth Year |
|---|---|---|
| Fumihide Esaka | CEO & Director | 1963 |
| Scott McLean Hanson Ph.D. | Co-Founder, CTO, Secretary & Director | 1984 |
| Jeffrey G. Winzeler | Chief Financial Officer | 1960 |
| Sean Chihhsiang Chen | President & COO | 1969 |
| David Blaauw | Co-Founder | – |
| Dennis Sylvester | Co-Founder | – |
| Lisa Standley | Senior Director of Finance and Administration | – |
| Charlene Wan | Vice President of Corporate Marketing & Investor Relations | – |
| Aaron Grassian | Executive Vice President of Global Sales & Marketing | – |
| Kris Potrafka | Vice President of Human Resources | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.